In oral cancer, stroma-derived CCL2 is a key player in recruiting myeloid-derived stem cells that express a receptor of CCL2, CCR2, from the bone marrow to the tumor microenvironment [72]. This evidence concerns the gene CCL2 and lip and oral cavity carcinoma.